| Financial Year |
September 30 2022 |
| Monetary Funds |
11,819,481.97 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
343,601,195.30 |
| Advances to Suppliers |
6,124,576.70 |
| Other Receivables |
45,541,154.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
452,379.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
12,637,147.39 |
| Other Current Assets |
14,190,503.35 |
| Total Current Assets |
434,366,438.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
20,419,870.04 |
| Investment Properties |
-- |
| Fixed Assetes |
149,385,858.27 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,745,242.04 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
730,337.37 |
| Deferred Income Tax Assets |
9,743,544.99 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
189,459,832.26 |
| Total Assets |
623,826,270.82 |
| Short-Term Loans |
255,060,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
75,074,291.70 |
| Accounts Received In Advance |
809,226.42 |
| Employee Compensation Payable |
16,925,256.07 |
| Taxes Payable |
7,681,328.12 |
| Interest Payable |
37,802,856.96 |
| Dividend Payable |
-- |
| Other payables |
89,995,237.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,692,884.36 |
| Other Current Liabilities |
61,425,365.35 |
| Sub-Total of Current Liabilities |
511,387,040.60 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
21,779,248.22 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
100,304,653.44 |
| Sub-Total of Non-Current Liabilities |
128,588,053.55 |
| Total Liabilities |
639,975,094.15 |
| Paid-In Capital(Or Share Stock) |
189,000,000.00 |
| Capital Surplus |
362,083,925.62 |
| Surplus Reserve |
24,712,518.58 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-589,876,790.28 |
| Minority Stockholder's Interest |
-2,068,477.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-14,080,346.08 |
| Owner's Equity（Stockholder's Equity） |
-16,148,823.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
623,826,270.82 |
